Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
2013 ◽
Vol 20
(1)
◽
pp. 233-245
◽
Geoffrey I. Shapiro
◽
Jordi Rodon
◽
Cynthia Bedell
◽
Eunice L. Kwak
◽
Jose Baselga
◽
...
2015 ◽
Vol 21
(9)
◽
pp. 2192-2192
◽
2014 ◽
Vol 32
(4)
◽
pp. 670-681
◽
Jordi Rodon
◽
Irene Braña
◽
Lillian L Siu
◽
Maja J De Jonge
◽
Natasha Homji
◽
...
2014 ◽
Vol 21
(1)
◽
pp. 77-86
◽
Debashis Sarker
◽
Joo Ern Ang
◽
Richard Baird
◽
Rebecca Kristeleit
◽
Krunal Shah
◽
...
2018 ◽
Vol 23
(4)
◽
pp. 401
◽
Gerald Edelman
◽
Jordi Rodon
◽
Joanne Lager
◽
Christelle Castell
◽
Jason Jiang
◽
...
Toshihiko Doi
◽
Yuichi Ando
◽
Hideaki Bando
◽
Takayuki Yoshino
◽
Megumi Inada
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3003-3003
◽
J. Baselga
◽
M. J. De Jonge
◽
J. Rodon
◽
H. A. Burris
◽
D. C. Birle
◽
...
2004 ◽
Vol 10
(8)
◽
pp. 2636-2644
◽
Helen J. Mackay
◽
Ronald Hoekstra
◽
Ferry A. L. M. Eskens
◽
Walker J. Loos
◽
Donna Crawford
◽
...
2011 ◽
Vol 17
(19)
◽
pp. 6304-6312
◽
Francesco Atzori
◽
Josep Tabernero
◽
Andrés Cervantes
◽
Ludmila Prudkin
◽
Jordi Andreu
◽
...
2011 ◽
Vol 30
(6)
◽
pp. 2294-2302
◽
Jason Konner
◽
Rachel N. Grisham
◽
Jae Park
◽
Owen A. O’Connor
◽
Gillian Cropp
◽
...
2007 ◽
Vol 13
(7)
◽
pp. 2109-2114
◽
Ramesh K. Ramanathan
◽
D. Lynn Kirkpatrick
◽
Chandra P. Belani
◽
David Friedland
◽
Sylvan B. Green
◽
...
Close
Export Citation Format
Close
Share Document
Close